Recovery of growth hormone release from suppression by exogenous insulin-like growth factor I (IGF-I): Evidence for a suppressive action of free rather than bound IGF-I

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 8, 1998, Pages 2836-2842

  Chapman, Ian M ^a,c   Hartman, Mark L ^a   Pieper, Karen S ^a   Skiles, Emily H ^a   Pezzoli, Suzan S ^a   Hintz, Raymond L ^b   Thorner, Michael O ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; GLUCOSE BLOOD LEVEL; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HORMONE INHIBITION; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM;

ADOLESCENT; ADULT; BLOOD GLUCOSE; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; KINETICS; MALE; RECOMBINANT PROTEINS;

EID: 0031757586     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.8.2836     Document Type: Article

References (44)

1. Jones JI, Clemmons DR. 1995 Insulin-like growth factors and their binding proteins: biological actions [Review]. Endocr Rev. 16:3-34.
2. Zenobi PD, Graf S, Ursprung H, Froesch ER. 1992 Effects of insulin-like growth factor I on insulin secretion and renal function in normal human subjects. Proc Natl Acad Sci USA. 86:2868-2872.
3. Hartman ML, Claylon PE, Johnson ML, et al. 1993 A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans. J Clin Invest. 91:2453-2462.
4. Bermann M, Jaffe CA, Tsai W, DeMott-Friberg R, Barkan AL. 1994 Negative feedback regulation of pulsatile growth hormone secretion by insulin-like growth factor I. Involvement of hypothalamic somatostatin. J Clin Invest. 94:138-145.
5. Ho KY, Veldhuis JD, Johnson ML, et al. 1988 Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J Clin Invest. 81:968-975.
6. Straus DS, Takemoto CD. 1990 Effect of fasting on insulin-like growth factor-I (IGF-I) and growth hormone receptor mRNA levels and IGF-I gene transcription in rat liver. Mol Endocrinol. 4:91-100.
7. Guevara-Aguirre J, Rosenbloom AL, Vaccarello MA, et al. 1991 Growth hormone receptor deficiency (Laron syndrome): clinical and genetic characteristics [Review]. Acta Paediatr Scand. 377(Suppl):96-103.
8. Lanes R, Recker B, Fort P, Lifshitz F. 1985 Impaired somatomedin generation test in children with insulin-dependent diabetes mellitus. Diabetes. 34:156-160.
9. Dunger DB, Edge JA, Pal R, Taylor AM, Holly JM, Matthews DR. 1991 Impact of increased growth hormone secretion on carbohydrate metabolism in adolescents with diabetes. Acta Paediatr Scand. 377(Suppl):69-77.
10. Vaccarello MA, Diamond Jr FB, Guevara-Aguirre J, et al. 1993 Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome. J Clin Endocrinol Metab. 77:273-280.
11. Cheetham TD, Jones J, Taylor AM, Holly J, Matthews DR, Dunger DB. 1993 The effects of recombinant insulin-like growth factor I administration on growth hormone levels and insulin requirements in adolescents with type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 36:678-681.
12. Berelowitz M, Szabo M, Frohman LA, Firestone S, Chu L, Hintz RL. 1981 Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science. 212:1279-1281.
13. Yamashita S, Melmed S. 1986 Insulin-like growth factor 1 action on rat anterior pituitary cells: suppression of growth hormone secretion and messenger ribonucleic acid levels. Endocrinology. 118:176-182.
14. Aguila MC, Boggaram V, McCann SM. 1993 Insulin-like growth factor I modulates hypothalamic somatostatin through a growth hormone releasing factor increased somatostatin release and messenger ribonucleic acid levels. Brain Res. 625:213-218.
15. Korbonits M, Little JA, Camacho-Hubner C, Trainer PJ, Besser GM, Grossman AB. 1996 Insulin-like growth factor-I and -II in combination inhibit the release of growth hormone-releasing hormone from the rat hypothalamus in vitro. Growth Regul. 6:110-120.
16. Sato M, Frohman LA. 1993 Differential effects of central and peripheral administration of growth hormone (GH) and insulin-like growth factor on hypothalamic GH-releasing hormone and somatostatin gene expression in GH-deficient dwarf rats. Endocrinology 133:793-799.
17. Guler HP, Zapf J, Schmid C, Froesch ER. 1989 Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinol (Copenh). 121:753-758.
18. Guler HP, Zapf J, Froesch ER. 1987 Short-term metabolic effects of recombinant human insulin-like growth factor in healthy adults. N Engl J Med. 317:137-140.
19. Chapman IM, Hartman ML, Pezzoli SS, et al. 1997 Effect of aging on the sensitivity of growth hormone secretion to insulin-like growth factor (IGF)-I negative feedback. J Clin Endocrinol Metab. 82:2996-3004.
20. Faria ACS, Bekenstein LW, Booth Jr RA, et al. 1992 Pulsatile growth hormone release in normal women. Clin Endocrinol (Oxf). 36:591-596.
21. DeFronzo RA, Tobin JD, Andres R. 1979 Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 237:E214-E223.
22. Chapman IM, Hartman ML, Straume M, Johnson ML, Veldhuis JD, Thorner MO. 1994 Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women. J Clin Endocrinol Metab. 78:1312-1319.
23. O'brien PC, Shampo MA. 1988 Statistical considerations for performing multiple tests in a single experiment. III. Repeated measures over time. Mayo Clin Proc. 63:918-920.
24. Crowder MJ, Hand DJ. 1990 Analysis of repeated measures. New York: Chapman and Hall.
25. Kaiser L. 1989 Adjusting for baseline: change or percentage change? Stat Med. 8:1183-1190.
26. Quabbe HJ, Schilling E, Helge H. 1966 Pattern of growth hormone secretion during a 24-hour fast in normal adults. J Clin Endocrinol Metab. 26:1173-1177.
27. Masuda A, Shibasaki T, Nakahara M, et al. 1985 The effect of glucose on growth hormone (GH)-releasing hormone-mediated GH secretion in man. J Clin Endocrinol Metab. 60:523-526.
28. Zapf J, Schmid C, Guler HP, et al. 1990 Regulation of binding proteins for insulin-like growth factor IGF) in humans. Increased expression of IGF binding protein 2 during IGF treatment in healthy adults and in patients with extrapancreatic tumor hypoglycemia. J Clin Invest. 86:952-961.
29. Lieberman SA, Bukar J, Chen SA, et al. 1992 Effects of recombinant human insulin-like growth factor-I (rhIGF-I) on total and tree IGF-I concentrations, IGF-binding proteins, and glycemic response in humans. J Clin Endocrinol Metab. 75:30-36.
30. Young SC, Underwood LE, Celniker A, Clemmons DR. 1992 Effects of recombinant insulin-like growth factor-I (IGF-I) and growth hormone on serum IGF-binding proteins in calorically restricted adults. J Clin Endocrinol Metab. 75:603-608.
31. Mendel CM. 1989 The free hormone hypothesis: a physiologically based mathematical model. Endocr Rev. 10:232-274.
32. Frystyk J, Vestbo E, Skjaerbaek C, Morgensen CE, Orskov H. 1995 Free insulin-like growth factors in human obesity. Metabolism. 44(Suppl 4):37-44.
33. Clark RG, Mortensen D, Reifsynder D, Mohler M, Etcheverry T, Mukku V. 1993 Recombinant human insulin-like growth factor binding protein-3 (rhIGFBP-3): effects on the glycemic and growth promoting activities of rhIGF-I in the rat. Growth Regul. 3:50-52.
34. Hasegewa T, Hasagewa Y, Takada M, Tsuchiya Y. 1995 The free form of insulin-like growth factor I increases in circulation during normal human pregnancy. J Clin Endocrinol Metab. 80:3284-3286.
35. Hasegewa Y, Hasagewa H, Fujii K, et al. 1997 High ratios of free to total insulin-like growth factor-I in early infancy. J Clin Endocrinol Metab. 82:156-158.
36. Skjaerbaek C, Vahl N, Frystyk J, et al. 1997 Serum free insulin-like growth factor-I in growth hormone deficient adults before and after growth hormone replacement. Eur J Endocrinol. 137:132-137.
37. Lieberman SA, Butterfield GE, Harrison D, Hoffman AR. 1994 Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndrome. J Clin Endocrinol Metab. 78:404-410.
38. Weber MM, Melmed S, Rosenbloom J, Yamasaki H, Prager D. 1992 Rat somatotroph insulin-like growth factor-II (IGF-II) signalling: role of the IGF-I receptor. Endocrinology. 131:2147-2153.
39. Clark RG, Carlsson LM, Rafferty B, Robinson IC. 1988 The rebound release of growth hormone (GH) following somatostatin infusion in rats involves hypothalamic GH-releasing factor release. J Endocrinol. 119:397-404.
40. Cella SG, Luceri M, Cattaneo L, Torsello A, Muller EE. 1996 Somatostatin withdrawal as generator of pulsatile GH release in the dog: a possible tool to evaluate the endogenous GHRH tone? Neuroendocrinology. 63:481-488.
41. Jaffe CA, DeMott-Friberg R, Barkan AL. 1946 Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli. J Clin Invest. 97:934-940.
42. Williams TC, Kelijman M, Crelin WC, Downs TR, Frohman LA. 1988 Differential effects of somatosatin (SRIH) and a SRIH analog, SMS 201-495, on the secretion of growth hormone and thyroid-stimulating hormone in man. J Clin Endocrinol Metab. 66:39-45.
43. Copeland KC, Underwood LE, Van Wyk JJ. 1980 Induction of immunoreactive somatomedin C in human serum by growth hormone: dose-response relationships and effects on chromatographic profiles. J Clin Endocrinol Metab. 50:690-697.
44. Jorgensen JOL, Moller N, Lauritzen T, Christiansen JS. 1990 Pulsatile vs. continuous intravenous administration of growth hormone (GH) in GH-deficient patients: effects on circulating insulin-like growth factor-I and metabolic indices. J Clin Endocrinol Metab. 70:1616-1623.